The Ernest and Helen Scott Haematological Research Institute

Thanks to the generous philanthropic support of The Scott-Waudby Charitable Trust, the University of Leicester has been able to establish a Haematological Research Institute that will enhance existing programs and make possible new initiatives in translational research in haemato-oncology. A summary of our vision and of our strengths can be found here.

We follow a programme of work covering four integrated streams:

  • Carry out basic science research activities to investigate the mechanisms of tumorigenesis and of resistance to therapies.
  • Develop new tools for diagnosis and stratification of patients for better response to therapies.
  • Develop new therapeutic agents and procedures.
  • Investigate the mechanisms of action of new therapies available in clinical trials and mechanism of resistance

Our strengths

  • Academic expertise
  • Clinical expertise
      • About 20 clinical trials are currently recruiting patients with Leukaemia and Lymphoma (ONO/GS4059)
      • Access to a large patient population covering Leicester, Northampton and Rutland
  • Translational research environment at Leicester:

Our Team:

Institute Director: Prof Martin Dyer

Institute Deputy Director: Prof Simon Wagner

Academic Clinical Lecturer: Dr Matt Ahearne

Institute Manager: Dr Sandrine Jayne

Clinical Research Fellow/PhD student: Dr Harriet Walter

Clinical Research Fellow/PhD Student: Dr Rebecca Allchin

Post-doc: Dr Larissa Lezina, Dr Shiqiu Xiong

PhD students: Mr Sami Mamand, Mr Matt Carr, Ms Afaf Alharthi, Mr Ross Jackson, Ms Victoria Smith

Research technicians: Ms Nadia Nawaz, Mr Gethin Thomas, Mr Chris Trethewey

Our collaborators in Leicester:

Prof Karen Brown

Prof Kelvin Cain

Dr Aude Echalier-Glazer

Dr Ildiko Gyory

Dr Salvador Macip

Prof Catrin Pritchard

Prof John Schwabe

Dr Meike Vogler

 

The list of our publications can be found here.

How to support us

Share this page:

NEWS

Powerful pre-clinical platform for anti-cancer drug and biomarker discovery

Pre-clinical models that can accurately predict outcomes in the clinic are much sort after in the field of cancer drug discovery and development.  Read about how patient derived explants offer many advantages and are the powerful model of choice. A copy of the review, published in the British Journal of Cancer, is available by clicking this link: PDE Platform

---------------------------------

SEND Study Success

Congratulations to Chris Avery, who with collaborating colleagues published findings of the SEND study, a multi-centre randomised trial using two different surgical protocols for mouth cancer treatment.  A nationwide first for this type of trial, using real-world data.  The paper, published in the British Journal of Cancer, is available by clicking this link: SEND Paper

---------------------------------

Centre Health and Wellbeing Group
Join up for a walk on the park Friday lunchtime - details here.

More information from Jenny McNair jm65@le.ac.uk

Contact Details

Leicester Cancer Research Centre
Robert Kilpatrick Clinical Sciences Building
University of Leicester
Leicester Royal Infirmary
Leicester LE2 7LX

T: +44 (0) 116 252 3170
E: cancerstudies@le.ac.uk

(Please note this email address should not be used for clinical referrals or patient correspondence)

Maps and Directions

Sat Nav users: 
LE1 5WW

Accessibility

AccessAble logo

The University of Leicester is committed to equal access to our facilities. DisabledGo has a detailed accessibility guide for the Robert Kilpatrick Clinical Sciences Building.

Seminars

.